Form D · Pharmaceuticals
CASI Pharmaceuticals, Inc.
Beijing, F4 · CIK 0001962738
Offering snapshot reported Apr 28, 2026 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 17, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2026 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Feb 26, 2026 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jan 28, 2026 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jan 28, 2026 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jul 15, 2024 | Initial | $15,000,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-582016
Source: Form D, filed Apr 28, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Cory | Director, Executive |
| Thomas Folinsbee | Director |
| Wei Gao | Executive |
| Wei Wu He | Director |
| Hai Huang | Executive |
| James Huang | Director |
| Barbara Krebs Pohl | Director |
| Kun Qian | Executive |
| Zhenbo Su | Director |
| Chunhua Wang | Executive |
| Alexander Y. Wu | Director |
| Xuebo Zeng | Director |
| Wei (Larry) Zhang | Executive |
| Alexander A. Zukiwski | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1701 1702, China Central Office Tower 1 No. 81 Jianguo Road, Chaoyang District
Beijing, F4, 100025
Phone: 86 10 6561 8789
Beijing, F4, 100025
Phone: 86 10 6561 8789